Example: Heart Attack

Clinical Trials on Glabellar Crease

Total 10000 results

NCT02523417

Completed

HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA）for Breast Cancer

Breast Cancer
NCT00455533

Completed

Study to Assess Effectiveness of Giving Combination of Standard Chemotherapy Drugs Versus Combination of Standard Chemotherapy and New Drug Ixabepilone When Given Before Surgical Removal of Early Stage Breast Cancer

Breast Cancer
NCT02491697

Active, not recruiting

Immunotherapy Combined With Capecitabine Versus Capecitabine Monotherapy in Advanced Breast Cancer

Breast Cancer
NCT01302002

Withdrawn

The Use of Metformin in Early Breast Cancer Patients Pre-Surgery

Breast Cancer
NCT01332981

Completed

An Observational Follow-up Study of 1st-Line Treatment With Herceptin (Trastuzumab) in Patients With Metastatic Breast Cancer (Post-HERMINE)

Breast Cancer
NCT02154139

Completed

Leuprorelin Acetate SR 11.25 mg for Injection Specified Drug-use Survey "Long-term Use Survey on Premenopausal Breast Cancer Patients (96 Weeks)"

Breast Cancer
NCT01410708

Withdrawn

TORI 104 Pre-Surgical Dasatinib

Breast Cancer
NCT02679586

Completed

Imaging Biomarker for Early Detection of Treatment Efficacy During Breast Cancer Neoadjuvant Chemotherapy

Breast Cancer
NCT00567554

Completed

Bevacizumab, Everolimus (RAD001), and Lapatinib as Neoadjuvant Chemotherapy Regimes for Primary Breast Cancer (GeparQuinto)

Breast Cancer
NCT01777932

Completed

AVAREG Study: An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Breast Cancer

Breast Cancer
NCT01890824

Terminated

Fat Metabolism Following Chemotherapy in Breast Cancer

Breast Cancer
NCT01018108

Completed

Visualization of the Effect of Acupuncture on Brain Serotonin in Breast Cancer Survivors

Breast Cancer
NCT00468585

Completed

Study of Biweekly Capecitabine Dosing With Bevacizumab for the Treatment of Metastatic Breast Cancer Based Upon the Norton-Simon Mathematical Model

Breast Cancer
NCT00769470

Completed

Docetaxel, Carboplatin, and Trastuzumab and/or Lapatinib in Treating Women With Stage I, Stage II, or Stage III Breast Cancer That Can Be Removed by Surgery

Breast Cancer
NCT01849978

Completed

Enhancing Exercise in Breast Cancer Survivors

Breast Cancer
NCT01692210

Completed

The Effect of Dexmedetomidine of the Immune System

Breast Cancer
NCT00605397

Completed

PET Imaging With Cu-64 Labeled Trastuzumab in HER2+ Metastatic Breast Cancer (Cu-64 HER2+)

Breast Cancer
NCT02058615

Completed

Feasibility Testing and Evaluation of an Online Toolkit for Male Spouses of Women With Breast Cancer

Breast Cancer
NCT00595062

Completed

Quadrant High Dose Rate Intraoperative Radiation Therapy (IORT) for Early-Stage Breast Cancer: A Pilot Study

Breast Cancer
NCT01074320

Completed

Measuring Musculoskeletal Symptoms in Patients Receiving Aromatase Inhibitors (AIMS)

Breast Cancer
NCT00347438

Terminated

Capecitabine as NeoAdjuvant Therapy in Locally Advanced Breast Cancer

Breast Cancer
NCT00193089

Completed

Docetaxel, Vinorelbine and Trastuzumab in the Treatment of Patients With Metastatic Her-2 Positive Breast Cancer

Breast Cancer
NCT00235235

Terminated

A Correlative Study for Predicting Response and Toxicity in Patients Receiving Chemotherapy for Breast Cancer

Breast Cancer
NCT00891969

Terminated

Treatment Decision Making Between Oncologists and Women With Newly Diagnosed Breast Cancer and Their Healthy Companions

Breast Cancer
NCT01004562

Completed

Collecting Information From Patients Enrolled in the Breast Specialized Program of Research Excellence

Breast Cancer
NCT00897338

Completed

Identifying Circulating Breast Cancer Cells in Women With Metastatic Breast Cancer

Breast Cancer
NCT00658281

Completed

Setup Variation in the Supraclavicular Lymph Nodes Treatment in Breast Cancer Patients

Breast Cancer
NCT01804309

Completed

Functional Anatomical Examination of Axillary Sentinel Lymph Node Drainage in the Axillary Subregions in Early Breast Cancer

Breast Cancer
NCT01496001

Completed

Cosmetic and Functional Outcomes After Breast Conserving Surgery

Breast Cancer
NCT01004081

Completed

Hormone Receptor Positive Metastatic Breast Cancer (HR+ mBC) BIIB021 Plus Aromasin Schedule Finding

Breast Cancer
NCT00754702

Terminated

Vinorelbine Metronomic Plus Lapatinib for Overexpressing HER-2 Metastatic Breast Cancer

Breast Cancer
NCT00095706

Completed

Treatment of HER2-Positive Metastatic Breast Cancer With Herceptin and Bevacizumab (Antibodies Against HER2 and VEGF)

Breast Cancer
NCT00421447

Completed

Bone Geometry and Muscle Density Changes in Postmenopausal Women and Breast Cancer Patients Prescribed Anastrozole

Breast Cancer
NCT00814034

Completed

Coagulation Parameters in Postmenopausal Breast Cancer Patients Under Adjuvant Hormonal Therapy (COPA)

Breast Cancer
NCT01797354

Completed

Impact of a Group Intervention on Breast Cancer Patient's Adjustment and Emotion Regulation at the End of Treatment

Breast Cancer
NCT00528567

Completed

BEATRICE Study: A Study of Bevacizumab (Avastin) Adjuvant Therapy in Triple Negative Breast Cancer

Breast Cancer
NCT01606072

Completed

Perioperative Use of Desmopressin (DDAVP) in Breast Cancer

Breast Cancer
NCT02491892

Completed

A Study of Pertuzumab in Participants With Metastatic Breast Cancer

Breast Cancer
NCT02525159

Completed

Effectiveness of DIM Supplements to Increase 2-OHE1/16 Ratio (EDIMI216OHE1)

Breast Cancer
NCT00647790

Completed

Positron Emission Tomography (PET) Using Hormone Receptor Ligands in Breast Cancer

Breast Cancer
NCT00820690

Unknown

Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer (LABC)

Breast Cancer
NCT00808041

Completed

Chemotherapy Monitoring With Breast Computed Tomography (CT)

Breast Cancer
NCT00779285

Terminated

Safety Study of CAELYX in Patients With Metastatic Breast Cancer Previously Treated With Anthracyclines (Study P04057)(TERMINATED)

Breast Neoplasm
NCT02010008

Completed

Screening Mammography and Latinas: A Multilevel Intervention

Breast Cancer
NCT01857882

Completed

Decision Support Workshop for Breast Reconstruction (DSW)

Breast Cancer
NCT00632489

Completed

LBH589 in Combination With Capecitabine Plus/Minus (±) Lapatinib in Breast Cancer Patients

Breast Cancer
NCT01332032

Completed

Promoting Breast Cancer Screening in Non-adherent Women

Breast Cancer
NCT01914614

Completed

A Pilot Study of Working Women and Breast Cancer

Breast Cancer
NCT02303145

Completed

Breast Cancer Survivorship & Work-Related Cognitive Limitation (BCSurvivorship)

Breast Cancer
NCT00351858

Terminated

Safety and Efficacy Study of the Trifunctional Antibody Ertumaxomab to Treat Patients With Advanced or Metastatic Breast Cancer (IV REXBC 02)

Breast Cancer | Breast Neoplasms

Clinical Trials on Glabellar Crease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations